Herbert Smith Freehills Kramer

Intellectual Property

Christine Willgoos litigates patent actions on behalf of pharmaceutical and biotechnology companies, leading trial and appellate teams in Hatch-Waxman and biologic drug litigation, often involving blockbuster drugs. She represents biotechnology companies, including advising on biosimilar litigation. Christine is an accomplished courtroom advocate with significant experience, including trials and appeals, preliminary injunctions, and Markman hearings. She has handled cases in genetics, molecular biology, biochemistry and drug development, including those concerning biologic drugs, recombinant DNA vectors, cancer drugs, antidepressant drugs and dermatologic drugs. Her work extends across other industries as well, including medical devices, semiconductors, telecommunications and electronics.